New drug cocktail aims to stall lung cancer in First-Line trial
NCT ID NCT05801029
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 22 times
Summary
This study tests whether combining two targeted drugs, osimertinib and amivantamab, can safely control advanced non-small cell lung cancer with a specific EGFR mutation. About 60 adults who have not had prior treatment for their advanced or metastatic disease will receive the drug combination. The main goals are to check side effects and see how long the cancer stays under control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER NSCLC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Hong Kong, 150001, Hong Kong
-
Research Site
Hong Kong, 999077, Hong Kong
-
Research Site
Hong Kong, Hong Kong
-
Research Site
Shatin, 00000, Hong Kong
-
Research Site
George Town, 10990, Malaysia
-
Research Site
Kota Bharu, 15586, Malaysia
-
Research Site
Kuala Lumpur, 50586, Malaysia
-
Research Site
Kuala Lumpur, 59100, Malaysia
-
Research Site
Kuantan, 25100, Malaysia
-
Research Site
Kuching, 93200, Malaysia
-
Research Site
Singapore, 169610, Singapore
-
Research Site
Singapore, 308433, Singapore
-
Research Site
Anyang-si, 14068, South Korea
-
Research Site
Busan, 49241, South Korea
-
Research Site
Daegu, 42415, South Korea
-
Research Site
Seoul, 08308, South Korea
-
Research Site
Seoul, 5030, South Korea
-
Research Site
Kaohsiung City, 82445, Taiwan
-
Research Site
Taichung, 404, Taiwan
-
Research Site
Taichung, 40705, Taiwan
-
Research Site
Tainan, 73657, Taiwan
-
Research Site
Taipei, 10048, Taiwan
-
Research Site
Taipei, 110, Taiwan
-
Research Site
Yunlin, 640, Taiwan
-
Research Site
Bangkok, 10330, Thailand
-
Research Site
Bangkok, 10400, Thailand
-
Research Site
Bangkok, 10700, Thailand
-
Research Site
Chiang Mai, 50200, Thailand
-
Research Site
Songkhla, 90110, Thailand
Conditions
Explore the condition pages connected to this study.